EUVIMEDEUVIMED entdecken
Delphi-StudieOpen Access · CC BY 4.0

What Matters Most? Developing a Core Patient Reported Outcome Set for Individuals With Genetic Intellectual Disabilities: An International Delphi Study

Nadia Y van Silfhout iD, Maud M van Muilekom iD, Leonie A Menke, Clara D van Karnebeek, Lotte Haverman, Agnies M van Eeghen

Journal of Intellectual Disability Research · 2026

DOI: 10.1111/jir.70081 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Journal of Intellectual Disability Research, 2026. Verfasst von Nadia Y van Silfhout und 5 weiteren Autor:innen. Beteiligte Einrichtung: Emma Children's Hospital, Department of Child and Adolescent Psychiatry & Psychosocial Care, Amsterdam UMC Location University of Amsterdam, Amsterda…. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Intellectual Disability. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ForWis(h)dom Foundation, 's Heeren Loo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Improving care and research for individuals with genetic intellectual disabilities (GID) requires the identification and measurement of relevant patient reported outcomes (PROs). PROs represent the patient perspective on their health status. Currently, a myriad of potentially irrelevant PROs is being measured for individuals with GID. Therefore, the aim of this study is to identify the most relevant PROs through a Delphi survey and consensus meetings and develop a generic core PRO set applicable to the whole GID population to be used in care and research.

Methods

PROs, previously identified through a comprehensive literature review and a qualitative study, were integrated and conceptualised into a pilot generic core PRO set with an expert group. This pilot set was presented in a two‐round Delphi survey with individuals with GID, caregivers and experts. Consensus was set at 60% or more of all participant groups rating a PRO as important for inclusion in the final core PRO set, or as not important for exclusion. The Delphi surveys were followed by two consensus meetings with individuals with GID, caregivers and experts to reach consensus on the undecided PROs.

Results

Twelve individuals with GID, 21 caregivers and 28 experts (total n = 61) participated in the first Delphi round. Twenty‐nine PROs were presented to the participants. In the first round, consensus was reached on one important PRO ‘fatigue’. In the second round, consensus was reached on 12 important PROs: fatigue, sleep, physical functioning/activities, quality of life, social functioning/participation, perceived health, cognitive functioning, depressive symptoms, mobility/functioning of the lower extremities, receptive communication, expressive communication and sensory overresponsivity. During the consensus meetings, consensus was reached on seven additional important PROs: pain, anxiety/stress, anger, vision, hearing, gastrointestinal symptoms and mental functioning. This resulted in a final generic core PRO set including the 19 PROs.

Conclusions

This study identified the most relevant PROs for GID, marking the final step in developing a generic core PRO set for the whole GID population. This GID core PRO set provides a framework to guide care, research and policymaking. The next step involves selecting and validating corresponding patient reported outcome measures (PROMs) to adequately measure these PROs: the GID core PROM set.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient Reported Outcome MeasuresIntellectual DisabilityHumansDelphi TechniqueAdultFemaleMaleMiddle AgedConsensusCaregiversYoung Adult

Stichwörter der Autor:innen

Delphi studyintellectual disabilitiespatient reported outcome measurespatient reported outcomesrare genetic neurodevelopmental disorders

Autor:innen und Institutionen

  • Emma Children's Hospital, Department of Child and Adolescent Psychiatry & Psychosocial Care, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.
  • Emma Children's Hospital, Department of Paediatrics, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.
  • Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, the Netherlands.
  • Mental Health and Personalized Medicine, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Child Development, Amsterdam Reproduction & Development Research Institute, Amsterdam, the Netherlands.
  • Mental Health and Digital Health, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

ORCID-Profile: Nadia Y van Silfhout, Maud M van Muilekom

Förderung

  • ForWis(h)dom Foundation
  • 's Heeren Loo

Zitieren

APA

van Silfhout, N. Y., van Muilekom, M. M., Menke, L. A., van Karnebeek, C. D., Haverman, L., & van Eeghen, A. M. (2026). What Matters Most? Developing a Core Patient Reported Outcome Set for Individuals With Genetic Intellectual Disabilities: An International Delphi Study. Journal of Intellectual Disability Research. https://doi.org/10.1111/jir.70081

Vancouver

van Silfhout NY, van Muilekom MM, Menke LA, van Karnebeek CD, Haverman L, van Eeghen AM. What Matters Most? Developing a Core Patient Reported Outcome Set for Individuals With Genetic Intellectual Disabilities: An International Delphi Study. Journal of Intellectual Disability Research. 2026. doi:10.1111/jir.70081

BibTeX
@article{vanSilfhout2026,
  author = {van Silfhout, Nadia Y and van Muilekom, Maud M and Menke, Leonie A and van Karnebeek, Clara D and Haverman, Lotte and van Eeghen, Agnies M},
  title = {What Matters Most? Developing a Core Patient Reported Outcome Set for Individuals With Genetic Intellectual Disabilities: An International Delphi Study},
  journal = {Journal of Intellectual Disability Research},
  year = {2026},
  doi = {10.1111/jir.70081}
}
Kostenlos starten →